Micafungin
Back to searchMolecule Structure
Scientific Name
Micafungin
Description of the Drug
Micafungin is an antifungal agent used for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, and for the prophylaxis of Candida infections during stem cell transplantation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01141
http://www.drugbank.ca/drugs/DB01141
Brand Name(s)
Mycamine
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Fresenius Kabi Usa Llc, Apotex Inc, Jiangsu Hansoh Pharmaceutical Group Co Ltd, Par Sterile Products Llc, Astellas Pharma Us Inc, Xellia Pharmaceuticals Aps, Hikma Pharmaceuticals International Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 1,3-beta-glucan synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL2364673 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL11893279 | ||
| PharmGKB | PA164781026 | ||
| Human Metabolome Database | HMDB0015272 | ||
| DrugBank | DB01141 | ||
| PubChem: Thomson Pharma | 16262692 | 14915042 | |
| PubChem | 477468 | ||
| Nikkaji | J1.154.979I | ||
| BindingDB | 50478216 | ||
| Brenda | 155389 | ||
| ChemicalBook | CB71471028 | ||
| rxnorm | MYCAMINE | MICAFUNGIN SODIUM | MICAFUNGIN |
| ChEBI | 600520 |
